Main Content

Press Release
WKR: Elekta receives notification that the U.S. Supreme Court denies opponent�s petition in patent dispute

ELEKTA RECEIVES NOTIFICATIONTHAT THE U.S. SUPREME COURT DENIES OPPONENT’S PETITION INPATENT DISPUTE

As previously announced, MedicalInstrumentation and Diagnostics Corporation (Midco), Elekta'sopponent in the U.S. patent dispute, in January filed a petitionfor a writ of certiorari with the United States Supreme Court.The petition requested the Supreme Court to review of the FederalCircuit's judgment vacating the prior judgment of the DistrictCourt in this case and absolving Elekta of all liability.

On March 29, the United StatesSupreme Court issued its decision denying MIDCO’s petitionfor a writ of certiorari.

Following the Federal Circuit’sjudgment in favor of Elekta, MIDCO has recently also filed amotion to amend its complaint in the District Court and requestedthat it be allowed to amend its case to be based on differentclaims of the patents in question. Elekta has opposed MIDCO’smotion. Elekta believes that it is unlikely that MIDCO couldprevail under any of the claims of the patents.

 

For further information, pleasecontact:
International: Peter Ejemyr, Group VP CorporateCommunications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com

United States: Lars Jonsteg, VPInvestor Relations North America, Elekta, USA
Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.com

Elekta is a world-leadingsupplier of advanced and innovative radiation oncology andneurosurgery solutions and services for precise treatment ofcancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.

For additional information aboutElekta, please visit www.elekta.com


This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download: